📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial (2017)

First Author: Ali H

Attributed to: Establishment of the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF] funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.10082

Publication URI: https://www.repository.cam.ac.uk/handle/1810/265685

Type: Journal Article/Review